United Kingdom Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

GlobalData
149 Pages - GLDATA57708
$5,995.00

Summary

GlobalData’s new report, "United Kingdom Diabetes Care Devices Market Outlook to 2022", provides key market data on the United Kingdom Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for Diabetes Care Devices market.
- Global corporate-level profiles of key companies operating within the United Kingdom Diabetes Care Devices market.
- Key players covered include LifeScan Inc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd
Sanofi
LifeScan Inc
Bayer HealthCare AG
Becton Dickinson and Co
Abbott Laboratories
Eli Lilly and Company
Novo Nordisk A/S
B. Braun Melsungen AG
Medtronic plc
Ypsomed Holding AG
A. Menarini Diagnostics S.r.l.

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Diabetes Care Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Diabetes Care Devices Market, United Kingdom 11
3.1 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2008-2022 11
3.2 Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2015 12
3.3 Diabetes Care Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2015 13
3.4 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2008-2015 14
3.5 Diabetes Care Devices Market, United Kingdom, Revenue ($m), 2015-2022 16
3.6 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2008-2022 18
3.7 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2008-2015 19
3.8 Diabetes Care Devices Market, United Kingdom, Volume (Units), 2015-2022 21
3.9 Diabetes Care Devices Market, United Kingdom, Company Share by Revenue ($m), 2015 23
4 Glucose Monitoring Market, United Kingdom 25
4.1 Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2015 25
4.2 Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2015 26
4.3 Glucose Monitoring Market, United Kingdom, Revenue ($m), 2008-2015 27
4.4 Glucose Monitoring Market, United Kingdom, Revenue ($m), 2015-2022 29
4.4.1 Blood Glucose Meters Market, United Kingdom, Revenue ($m), by Segment, 2008-2015 31
4.4.2 Blood Glucose Meters Market, United Kingdom, Revenue ($m), by Segment, 2015-2022 33
4.5 Glucose Monitoring Market, United Kingdom, Volume (Units), 2008-2015 35
4.6 Glucose Monitoring Market, United Kingdom, Volume (Units), 2015-2022 37
4.6.1 Blood Glucose Meters Market, United Kingdom, Volume (Units), by Segment, 2008-2015 39
4.6.2 Blood Glucose Meters Market, United Kingdom, Volume (Units), by Segment, 2015-2022 41
4.7 Glucose Monitoring Market, United Kingdom, Distribution Share by Revenue ($m), 2014-2015 43
4.8 Glucose Monitoring Market, United Kingdom, Company Share by Revenue ($m), 2015 44
5 Insulin Delivery Market, United Kingdom 46
5.1 Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2015 46
5.2 Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2015 47
5.3 Insulin Delivery Market, United Kingdom, Revenue ($m), 2008-2015 48
5.4 Insulin Delivery Market, United Kingdom, Revenue ($m), 2015-2022 50
5.4.1 Insulin Pens Market, United Kingdom, Revenue ($m), by Segment, 2008-2015 52
5.4.2 Insulin Pumps Market, United Kingdom, Revenue ($m), by Segment, 2008-2015 54
5.4.3 Insulin Pens Market, United Kingdom, Revenue ($m), by Segment, 2015-2022 56
5.4.4 Insulin Pumps Market, United Kingdom, Revenue ($m), by Segment, 2015-2022 58
5.5 Insulin Delivery Market, United Kingdom, Volume (Units), 2008-2015 60
5.6 Insulin Delivery Market, United Kingdom, Volume (Units), 2015-2022 62
5.6.1 Insulin Pens Market, United Kingdom, Volume (Units), by Segment, 2008-2015 64
5.6.2 Insulin Pumps Market, United Kingdom, Volume (Units), by Segment, 2008-2015 66
5.6.3 Insulin Pens Market, United Kingdom, Volume (Units), by Segment, 2015-2022 68
5.6.4 Insulin Pumps Market, United Kingdom, Volume (Units), by Segment, 2015-2022 70
5.7 Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), 2014-2015 72
5.8 Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), 2015 73
6 Overview of Key Companies in United Kingdom, Diabetes Care Devices Market 75
6.1 F. Hoffmann-La Roche Ltd 75
6.1.1 Company Overview 75
6.2 Sanofi 75
6.2.1 Company Overview 75
6.3 LifeScan Inc 75
6.3.1 Company Overview 75
6.4 Bayer HealthCare AG 75
6.4.1 Company Overview 75
6.5 Becton Dickinson and Co 76
6.5.1 Company Overview 76
6.6 Abbott Laboratories 76
6.6.1 Company Overview 76
6.7 Eli Lilly and Company 76
6.7.1 Company Overview 76
6.8 Novo Nordisk A/S 77
6.8.1 Company Overview 77
6.9 B. Braun Melsungen AG 77
6.9.1 Company Overview 77
6.10 Medtronic plc 77
6.10.1 Company Overview 77
6.11 Ypsomed Holding AG 77
6.11.1 Company Overview 77
6.12 A. Menarini Diagnostics S.r.l. 78
6.12.1 Company Overview 78
7 Diabetes Care Devices Market Pipeline Products 79
8 Financial Deals Landscape 80
8.1 Equity Offerings 80
8.1.1 Midatech Pharma Raises USD14.9 Million in Private Placement of Shares 80
8.1.2 EKF Diagnostics Raises USD7 Million in Private Placement of Shares 81
8.1.3 HCi Viocare to Raise up to USD34 Million in Public Offering of Shares 82
8.2 Partnerships 83
8.2.1 JDRF Enters into Co-Development Agreement with Arecor 83
8.2.2 Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 84
8.2.3 Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche 85
8.2.4 Medtronic and Qualcomm Life Enter into Co-Development Agreement 86
8.2.5 Metabolon Enters into Licensing Agreement with Synlab 87
8.2.6 Cellnovo Enters into Agreement with Roche Diagnostics 88
9 Recent Developments 89
9.1 Corporate Communications 89
9.1.1 Dec 02, 2016: Cambridge University Hospitals appoints new COO 89
9.1.2 Nov 24, 2016: Smiths announces new Non-executive Director 89
9.1.3 Nov 09, 2016: Change To Astrazeneca Board Of Directors 90
9.1.4 Sep 28, 2016: Change To Astrazeneca Board Of Directors 90
9.1.5 Sep 09, 2016: Tunstall Announces New Chief Executive Officer 90
9.1.6 Jul 11, 2016: EKF Diagnostics Holdings Appoints Carl Dominic Contadini As Non-Executive Director 91
9.1.7 Jun 09, 2016: Cellnovo appoints John Brooks as Chairman of the Board of Directors 91
9.1.8 May 09, 2016: EKF Diagnostics Announces Directorate Change 92
9.1.9 Apr 27, 2016: Smiths announces new Non-executive Director 92
9.1.10 Apr 20, 2016: EKF Diagnostics Holdings Announces Directorate Change 92
9.1.11 Apr 08, 2016: EKF Diagnostics Holdings Announces Directorate Change 93
9.1.12 Jan 28, 2016: LivaNova Receives Regulatory Approval in Japan for KORA 250 93
9.1.13 Jan 14, 2016: John Crane management change 94
9.2 Financial Announcements 95
9.2.1 Nov 10, 2016: AstraZeneca: Year-To-Date and Q3 2016 Results 95
9.2.2 Sep 28, 2016: Smiths Group: Annual results for the year ended 31 July 2016 108
9.2.3 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report 109
9.2.4 Sep 02, 2016: Midatech Pharma: Interim results for the six months ended 30 June 2016 112
9.2.5 Jul 28, 2016: AstraZeneca: H1 2016 Results 113
9.2.6 Apr 13, 2016: Midatech Pharma Announces Audited financial results for the year ended 31 December 2015 126
9.2.7 Apr 13, 2016: Midatech Pharma Audited financial results for the year ended 31 December 2015 126
9.2.8 Apr 12, 2016: EKF Diagnostics Holdings: Final results 133
9.2.9 Apr 11, 2016: SteadyMed Announces Initiation Of Inter Partes Review Proceedings By U.S. Patent And Trademark Office Against A United Therapeutics Patent 137
9.3 Legal And Regulatory 139
9.3.1 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 139
9.3.2 Jul 04, 2016: Infringement procedure against Roche - EMA update 139
9.3.3 Mar 16, 2016: Decision Diagnostics and Subsidiaries Elaborate on the Patent Infringement Lawsuit Against Johnson & Johnson and Two of Its Divisions 140
9.4 Other Significant Developments 141
9.4.1 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 141
9.4.2 Oct 13, 2016: Vigmed Signs Distribution Agreement For The Important Markets In The United Kingdom And Ireland 142
9.4.3 Mar 30, 2016: Mologic Selects for SBRI Healthcare Award 142
9.5 Strategy And Business Planning 142
9.5.1 Nov 14, 2016: Diabetes Management Leader Dexcom Expands Presence in EMEA Markets with new Edinburgh HQ 142
9.5.2 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 143
9.5.3 Jan 25, 2016: AstraZeneca partners with peers and academia to establish translational research fund 144
10 Appendix 145
10.1 Research Methodology 146
10.1.1 Coverage 146
10.1.2 Secondary Research 146
10.1.3 Primary Research 147
10.1.4 Company Share Analysis 147
10.1.5 Distribution Share Analysis 147
10.1.6 Benchmarking 148
10.2 GlobalData Consulting 148
10.3 Contact Us 148
10.4 Disclaimer 149

1.1 List of Tables
Table 1: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, 2008-2022 11
Table 2: Diabetes Care Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2015 13
Table 3: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 15
Table 4: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 17
Table 5: Diabetes Care Devices Market, United Kingdom, Volume (Units), 2008-2022 18
Table 6: Diabetes Care Devices Market, United Kingdom, Volume (Units), Historic, 2008-2015 20
Table 7: Diabetes Care Devices Market, United Kingdom, Volume (Units), Forecast, 2015-2022 22
Table 8: Diabetes Care Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2015 24
Table 9: Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2015 26
Table 10: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 28
Table 11: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 30
Table 12: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 32
Table 13: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 34
Table 14: Glucose Monitoring Market, United Kingdom, Volume (Units), Historic, 2008-2015 36
Table 15: Glucose Monitoring Market, United Kingdom, Volume (Units), Forecast, 2015-2022 38
Table 16: Blood Glucose Meters Market, United Kingdom, Volume (Units), Historic, 2008-2015 40
Table 17: Blood Glucose Meters Market, United Kingdom, Volume (Units), Forecast, 2015-2022 42
Table 18: Glucose Monitoring Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2014-2015 43
Table 19: Glucose Monitoring Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2015 45
Table 20: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2015 47
Table 21: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 49
Table 22: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 51
Table 23: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 53
Table 24: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 55
Table 25: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 57
Table 26: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 59
Table 27: Insulin Delivery Market, United Kingdom, Volume (Units), Historic, 2008-2015 61
Table 28: Insulin Delivery Market, United Kingdom, Volume (Units), Forecast, 2015-2022 63
Table 29: Insulin Pens Market, United Kingdom, Volume (Units), Historic, 2008-2015 65
Table 30: Insulin Pumps Market, United Kingdom, Volume (Units), Historic, 2008-2015 67
Table 31: Insulin Pens Market, United Kingdom, Volume (Units), Forecast, 2015-2022 69
Table 32: Insulin Pumps Market, United Kingdom, Volume (Units), Forecast, 2015-2022 71
Table 33: Insulin Delivery Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2014-2015 72
Table 34: Insulin Delivery Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2015 74
Table 35: Diabetes Care Devices Market Pipeline Products 79
Table 36: Midatech Pharma Raises USD14.9 Million in Private Placement of Shares 80
Table 37: EKF Diagnostics Raises USD7 Million in Private Placement of Shares 81
Table 38: HCi Viocare to Raise up to USD34 Million in Public Offering of Shares 82
Table 39: JDRF Enters into Co-Development Agreement with Arecor 83
Table 40: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 84
Table 41: Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche 85
Table 42: Medtronic and Qualcomm Life Enter into Co-Development Agreement 86
Table 43: Metabolon Enters into Licensing Agreement with Synlab 87
Table 44: Cellnovo Enters into Agreement with Roche Diagnostics 88

1.2 List of Figures
Figure 1: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, 2008-2022 11
Figure 2: Diabetes Care Devices Market, United Kingdom, Revenue Mix ($m), 2015 12
Figure 3: Diabetes Care Devices Market, United Kingdom, Category Contribution (%), 2015 13
Figure 4: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 14
Figure 5: Diabetes Care Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 16
Figure 6: Diabetes Care Devices Market, United Kingdom, Volume (Units), 2008-2022 18
Figure 7: Diabetes Care Devices Market, United Kingdom, Volume (Units), Historic, 2008-2015 19
Figure 8: Diabetes Care Devices Market, United Kingdom, Volume (Units), Forecast, 2015-2022 21
Figure 9: Diabetes Care Devices Market, United Kingdom, Company Share (%) 2015 23
Figure 10: Glucose Monitoring Market, United Kingdom, Revenue Mix ($m), 2015 25
Figure 11: Glucose Monitoring Market, United Kingdom, Segment Contribution (%), 2015 26
Figure 12: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 27
Figure 13: Glucose Monitoring Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 29
Figure 14: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 31
Figure 15: Blood Glucose Meters Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 33
Figure 16: Glucose Monitoring Market, United Kingdom, Volume (Units), Historic, 2008-2015 35
Figure 17: Glucose Monitoring Market, United Kingdom, Volume (Units), Forecast, 2015-2022 37
Figure 18: Blood Glucose Meters Market, United Kingdom, Volume (Units), Historic, 2008-2015 39
Figure 19: Blood Glucose Meters Market, United Kingdom, Volume (Units), Forecast, 2015-2022 41
Figure 20: Glucose Monitoring Market, United Kingdom, Company Share (%) 2015 44
Figure 21: Insulin Delivery Market, United Kingdom, Revenue Mix ($m), 2015 46
Figure 22: Insulin Delivery Market, United Kingdom, Segment Contribution (%), 2015 47
Figure 23: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 48
Figure 24: Insulin Delivery Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 50
Figure 25: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 52
Figure 26: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2008-2015 54
Figure 27: Insulin Pens Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 56
Figure 28: Insulin Pumps Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2015-2022 58
Figure 29: Insulin Delivery Market, United Kingdom, Volume (Units), Historic, 2008-2015 60
Figure 30: Insulin Delivery Market, United Kingdom, Volume (Units), Forecast, 2015-2022 62
Figure 31: Insulin Pens Market, United Kingdom, Volume (Units), Historic, 2008-2015 64
Figure 32: Insulin Pumps Market, United Kingdom, Volume (Units), Historic, 2008-2015 66
Figure 33: Insulin Pens Market, United Kingdom, Volume (Units), Forecast, 2015-2022 68
Figure 34: Insulin Pumps Market, United Kingdom, Volume (Units), Forecast, 2015-2022 70
Figure 35: Insulin Delivery Market, United Kingdom, Company Share (%) 2015 73

$5,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports